雾化吸入布地奈德混悬液、特布他林雾化液治疗小儿支气管肺炎140例

Budesonide inhalation suspension,terbutaline atomization treatment of children bronchial pneumonia 140 cases

目的:探讨氧气驱动雾化吸入布地奈德混悬液、特布他林雾化液辅助治疗小儿急性支气管肺炎的疗效。方法:选取本院280例急性支气管肺炎患儿,将其随机分为治疗组和对照组各140例,据患儿病情均给予抗感染对症治疗,在此基础上,两组均用糜蛋白酶氧气驱动雾化吸入,治疗组加用布地奈德混悬液、特布他林雾化液氧气驱动雾化吸入。结果:治疗组小儿临床症状咳嗽、痰鸣、喘息及肺部体征干湿啰音消失时间均明显快于对照组,两组差异有统计学意义(P<0.01)。1周后咳嗽、痰鸣、喘息及肺部体征消失者,治疗组128例(91.43%),对照组96例(68.57%),两组差异有统计学意义(P<0.005);10d后上述症状体征消失者,治疗组135例(96.43%),对照组123例(87.86%),两组差异有统计学意义(P<0.01)。结论:氧气驱动雾化吸入布地奈德混悬液和特布他林雾化液辅助治疗小儿支气管肺炎,疗效肯定,值得临床推广。

Objective：To study the therapy efficacy of oxygen-driven budesonide inhalation suspension,terbutaline aerosol in treatment of acute pneumonia.Methods：280 cases with acute bronchial pneumonia were randomly divided into treatment group 140 cases and control group 140 cases,according to children with symptomatic disease were treated with anti-infective therapy,on this basis,the two groups with chymotrypsin atomizing inhalation inhalation,the treatment group received budesonide suspension,terbutaline atomization driven by oxygen inhalation.Results：The treatment group of clinical symptoms in children about cough,phlegm,wheezing,and pulmonary signs about wet and dry rales disappeared were all significantly faster than thoses of the control group,the difference was statistically significant （P0.01）.One week after treatment,coughing,phlegm,wheezing,and lung signs disappeared in the treatment group were 128 patients （91.43%）,control group were 96 cases （68.57%）,the difference was significant （P0.005）;Ten days after treatment,coughing,phlegm,wheezing,and lung signs disappeared in the treatment group were 135 patients （96.43%）,control group were 123 cases （87.86%）,the difference was significant （P 0.01）.Conclusion：Oxygen-driven budesonide inhalation suspension and terbutaline aerosol therapy on children is effective and bronchial pneumonia.